In this study, we showed that inactivation of Tbx1 in the AHF using Mef2c-AHF-Cre allele, results in a PTA that is also observed in the most seriously affected 22q11.2DS (velo-cardio-facial/DiGeorge syndrome) patients. This evidence concerns the gene TBX1 and 22q11.2 deletion syndrome.